Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease
Nefrologia. 2013 Nov 13;33(6):864-6.
doi: 10.3265/Nefrologia.pre2013.Jul.12040.
[Article in
English,
Spanish]
Authors
José J Ribés-Cruz, Isidro Torregrosa-Maicas, Carmela Ramos-Tomás, Miguel A Solís-Salguero, M José Puchades-Montesa, Miguel A González-Rico, Isabel Juan-García, Patricia Tomás-Simó, Sandra Tejedor-Alonso, Patricia Zambrano-Esteves, Alfonso Miguel-Carrasco
No abstract available
MeSH terms
-
Aged, 80 and over
-
Atrial Fibrillation / complications
-
Benzimidazoles / administration & dosage
-
Benzimidazoles / adverse effects*
-
Benzimidazoles / pharmacokinetics
-
Benzimidazoles / therapeutic use
-
Dabigatran
-
Diabetes Mellitus, Type 2 / complications
-
Erythrocyte Transfusion
-
Female
-
Gastrointestinal Hemorrhage / chemically induced*
-
Gastrointestinal Hemorrhage / diagnosis
-
Gastrointestinal Hemorrhage / therapy
-
Glomerular Filtration Rate
-
Humans
-
Hypertension / complications
-
Metabolic Clearance Rate
-
Renal Dialysis
-
Renal Insufficiency, Chronic / complications*
-
Renal Insufficiency, Chronic / metabolism
-
Renal Insufficiency, Chronic / therapy
-
Thrombophilia / drug therapy*
-
Thrombophilia / etiology
-
Urinary Tract Infections / complications
-
beta-Alanine / administration & dosage
-
beta-Alanine / adverse effects
-
beta-Alanine / analogs & derivatives*
-
beta-Alanine / pharmacokinetics
-
beta-Alanine / therapeutic use
Substances
-
Benzimidazoles
-
beta-Alanine
-
Dabigatran